 | • レポートコード：MRC23Q38007 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の牛黄解毒錠市場について調査・分析し、世界の牛黄解毒錠市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（処方せん、店頭（OTC））、用途別セグメント分析（病院、クリニック、薬局、通販、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Chongqing Shengao Biochemical Pharmaceutical Co.,Ltd.、Sichuan Gaoyuanmingzhu Pharmaceutical Co.,Ltd.、Xian Zili Chinese Medicine Group Co., Ltd.、Xi'An Efanggong Pharmaceutical Co.,Ltd.、Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd.、CR Sanjiu、Hubei Renyue Pharmaceutical Co., Ltd.、Hubei NewLand Pharmaceutical Co., Ltd.、Li Shizhen Pharmaceutical Group Co., Ltd.などが含まれています。 世界の牛黄解毒錠市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、牛黄解毒錠市場規模を推定する際に考慮しました。本レポートは、牛黄解毒錠の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、牛黄解毒錠に関するビジネス上の意思決定に役立てることを目的としています。 ・牛黄解毒錠市場の概要 - 製品の定義 - 牛黄解毒錠のタイプ別セグメント - 世界の牛黄解毒錠市場規模：タイプ別分析（処方せん、店頭（OTC）） - 牛黄解毒錠の用途別セグメント - 世界の牛黄解毒錠市場規模：用途別分析（病院、クリニック、薬局、通販、その他） - 世界の牛黄解毒錠市場規模予測（2018年-2029年） - 牛黄解毒錠の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 牛黄解毒錠市場の競争状況およびトレンド ・牛黄解毒錠の地域別市場規模 - 北米の牛黄解毒錠市場規模（2018年-2029年） - アメリカの牛黄解毒錠市場規模（2018年-2029年） - ヨーロッパの牛黄解毒錠市場規模（2018年-2029年） - アジア太平洋の牛黄解毒錠市場規模（2018年-2029年） - 中国の牛黄解毒錠市場規模（2018年-2029年） - 日本の牛黄解毒錠市場規模（2018年-2029年） - 韓国の牛黄解毒錠市場規模（2018年-2029年） - インドの牛黄解毒錠市場規模（2018年-2029年） - オーストラリアの牛黄解毒錠市場規模（2018年-2029年） - 中南米の牛黄解毒錠市場規模（2018年-2029年） - 中東・アフリカの牛黄解毒錠市場規模（2018年-2029年） ・タイプ別セグメント：処方せん、店頭（OTC） - 世界の牛黄解毒錠のタイプ別販売量（2018年-2023年） - 世界の牛黄解毒錠のタイプ別売上（2018年-2023年） - 世界の牛黄解毒錠のタイプ別価格 ・用途別セグメント：病院、クリニック、薬局、通販、その他 - 世界の牛黄解毒錠の用途別販売量（2018年-2023年） - 世界の牛黄解毒錠の用途別売上（2018年-2023年） - 世界の牛黄解毒錠の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Chongqing Shengao Biochemical Pharmaceutical Co.,Ltd.、Sichuan Gaoyuanmingzhu Pharmaceutical Co.,Ltd.、Xian Zili Chinese Medicine Group Co., Ltd.、Xi'An Efanggong Pharmaceutical Co.,Ltd.、Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd.、CR Sanjiu、Hubei Renyue Pharmaceutical Co., Ltd.、Hubei NewLand Pharmaceutical Co., Ltd.、Li Shizhen Pharmaceutical Group Co., Ltd. ・産業チェーンと販売チャネルの分析 - 牛黄解毒錠産業チェーン分析 - 牛黄解毒錠の主要原材料 - 牛黄解毒錠の販売チャネル - 牛黄解毒錠のディストリビューター - 牛黄解毒錠の主要顧客 ・牛黄解毒錠市場ダイナミクス - 牛黄解毒錠の業界動向 - 牛黄解毒錠市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
The Niu Huang Jie Du Pian is a trusted and safe all herbal formula to maintain balance of the body and organ function without harsh side effects.
Highlights
The global Niuhuangjiedu Pill market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Niuhuangjiedu Pill is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Niuhuangjiedu Pill is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Niuhuangjiedu Pill include Chongqing Shengao Biochemical Pharmaceutical Co.,Ltd., Sichuan Gaoyuanmingzhu Pharmaceutical Co.,Ltd., Xian Zili Chinese Medicine Group Co., Ltd., Xi’An Efanggong Pharmaceutical Co.,Ltd., Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd., CR Sanjiu, Hubei Renyue Pharmaceutical Co., Ltd., Hubei NewLand Pharmaceutical Co., Ltd. and Li Shizhen Pharmaceutical Group Co., Ltd., etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Niuhuangjiedu Pill, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Niuhuangjiedu Pill.
The Niuhuangjiedu Pill market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Niuhuangjiedu Pill market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Niuhuangjiedu Pill manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chongqing Shengao Biochemical Pharmaceutical Co.,Ltd.
Sichuan Gaoyuanmingzhu Pharmaceutical Co.,Ltd.
Xian Zili Chinese Medicine Group Co., Ltd.
Xi’An Efanggong Pharmaceutical Co.,Ltd.
Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd.
CR Sanjiu
Hubei Renyue Pharmaceutical Co., Ltd.
Hubei NewLand Pharmaceutical Co., Ltd.
Li Shizhen Pharmaceutical Group Co., Ltd.
Segment by Type
Prescription Medicine
Over The Counter（OTC）
Segment by Application
Hospital
Clinic
Pharmacy
Sales Online
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Niuhuangjiedu Pill manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Niuhuangjiedu Pill in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Niuhuangjiedu Pill Market Overview
1.1 Product Overview and Scope of Niuhuangjiedu Pill
1.2 Niuhuangjiedu Pill Segment by Type
1.2.1 Global Niuhuangjiedu Pill Market Value Comparison by Type (2023-2029)
1.2.2 Prescription Medicine
1.2.3 Over The Counter（OTC）
1.3 Niuhuangjiedu Pill Segment by Application
1.3.1 Global Niuhuangjiedu Pill Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Sales Online
1.3.6 Others
1.4 Global Niuhuangjiedu Pill Market Size Estimates and Forecasts
1.4.1 Global Niuhuangjiedu Pill Revenue 2018-2029
1.4.2 Global Niuhuangjiedu Pill Sales 2018-2029
1.4.3 Global Niuhuangjiedu Pill Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Niuhuangjiedu Pill Market Competition by Manufacturers
2.1 Global Niuhuangjiedu Pill Sales Market Share by Manufacturers (2018-2023)
2.2 Global Niuhuangjiedu Pill Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Niuhuangjiedu Pill Average Price by Manufacturers (2018-2023)
2.4 Global Niuhuangjiedu Pill Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Niuhuangjiedu Pill, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Niuhuangjiedu Pill, Product Type & Application
2.7 Niuhuangjiedu Pill Market Competitive Situation and Trends
2.7.1 Niuhuangjiedu Pill Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Niuhuangjiedu Pill Players Market Share by Revenue
2.7.3 Global Niuhuangjiedu Pill Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Niuhuangjiedu Pill Retrospective Market Scenario by Region
3.1 Global Niuhuangjiedu Pill Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Niuhuangjiedu Pill Global Niuhuangjiedu Pill Sales by Region: 2018-2029
3.2.1 Global Niuhuangjiedu Pill Sales by Region: 2018-2023
3.2.2 Global Niuhuangjiedu Pill Sales by Region: 2024-2029
3.3 Global Niuhuangjiedu Pill Global Niuhuangjiedu Pill Revenue by Region: 2018-2029
3.3.1 Global Niuhuangjiedu Pill Revenue by Region: 2018-2023
3.3.2 Global Niuhuangjiedu Pill Revenue by Region: 2024-2029
3.4 North America Niuhuangjiedu Pill Market Facts & Figures by Country
3.4.1 North America Niuhuangjiedu Pill Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Niuhuangjiedu Pill Sales by Country (2018-2029)
3.4.3 North America Niuhuangjiedu Pill Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Niuhuangjiedu Pill Market Facts & Figures by Country
3.5.1 Europe Niuhuangjiedu Pill Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Niuhuangjiedu Pill Sales by Country (2018-2029)
3.5.3 Europe Niuhuangjiedu Pill Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Niuhuangjiedu Pill Market Facts & Figures by Country
3.6.1 Asia Pacific Niuhuangjiedu Pill Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Niuhuangjiedu Pill Sales by Country (2018-2029)
3.6.3 Asia Pacific Niuhuangjiedu Pill Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Niuhuangjiedu Pill Market Facts & Figures by Country
3.7.1 Latin America Niuhuangjiedu Pill Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Niuhuangjiedu Pill Sales by Country (2018-2029)
3.7.3 Latin America Niuhuangjiedu Pill Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Niuhuangjiedu Pill Market Facts & Figures by Country
3.8.1 Middle East and Africa Niuhuangjiedu Pill Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Niuhuangjiedu Pill Sales by Country (2018-2029)
3.8.3 Middle East and Africa Niuhuangjiedu Pill Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Niuhuangjiedu Pill Sales by Type (2018-2029)
4.1.1 Global Niuhuangjiedu Pill Sales by Type (2018-2023)
4.1.2 Global Niuhuangjiedu Pill Sales by Type (2024-2029)
4.1.3 Global Niuhuangjiedu Pill Sales Market Share by Type (2018-2029)
4.2 Global Niuhuangjiedu Pill Revenue by Type (2018-2029)
4.2.1 Global Niuhuangjiedu Pill Revenue by Type (2018-2023)
4.2.2 Global Niuhuangjiedu Pill Revenue by Type (2024-2029)
4.2.3 Global Niuhuangjiedu Pill Revenue Market Share by Type (2018-2029)
4.3 Global Niuhuangjiedu Pill Price by Type (2018-2029)
5 Segment by Application
5.1 Global Niuhuangjiedu Pill Sales by Application (2018-2029)
5.1.1 Global Niuhuangjiedu Pill Sales by Application (2018-2023)
5.1.2 Global Niuhuangjiedu Pill Sales by Application (2024-2029)
5.1.3 Global Niuhuangjiedu Pill Sales Market Share by Application (2018-2029)
5.2 Global Niuhuangjiedu Pill Revenue by Application (2018-2029)
5.2.1 Global Niuhuangjiedu Pill Revenue by Application (2018-2023)
5.2.2 Global Niuhuangjiedu Pill Revenue by Application (2024-2029)
5.2.3 Global Niuhuangjiedu Pill Revenue Market Share by Application (2018-2029)
5.3 Global Niuhuangjiedu Pill Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Chongqing Shengao Biochemical Pharmaceutical Co.,Ltd.
6.1.1 Chongqing Shengao Biochemical Pharmaceutical Co.,Ltd. Corporation Information
6.1.2 Chongqing Shengao Biochemical Pharmaceutical Co.,Ltd. Description and Business Overview
6.1.3 Chongqing Shengao Biochemical Pharmaceutical Co.,Ltd. Niuhuangjiedu Pill Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Chongqing Shengao Biochemical Pharmaceutical Co.,Ltd. Niuhuangjiedu Pill Product Portfolio
6.1.5 Chongqing Shengao Biochemical Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.2 Sichuan Gaoyuanmingzhu Pharmaceutical Co.,Ltd.
6.2.1 Sichuan Gaoyuanmingzhu Pharmaceutical Co.,Ltd. Corporation Information
6.2.2 Sichuan Gaoyuanmingzhu Pharmaceutical Co.,Ltd. Description and Business Overview
6.2.3 Sichuan Gaoyuanmingzhu Pharmaceutical Co.,Ltd. Niuhuangjiedu Pill Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sichuan Gaoyuanmingzhu Pharmaceutical Co.,Ltd. Niuhuangjiedu Pill Product Portfolio
6.2.5 Sichuan Gaoyuanmingzhu Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.3 Xian Zili Chinese Medicine Group Co., Ltd.
6.3.1 Xian Zili Chinese Medicine Group Co., Ltd. Corporation Information
6.3.2 Xian Zili Chinese Medicine Group Co., Ltd. Description and Business Overview
6.3.3 Xian Zili Chinese Medicine Group Co., Ltd. Niuhuangjiedu Pill Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Xian Zili Chinese Medicine Group Co., Ltd. Niuhuangjiedu Pill Product Portfolio
6.3.5 Xian Zili Chinese Medicine Group Co., Ltd. Recent Developments/Updates
6.4 Xi’An Efanggong Pharmaceutical Co.,Ltd.
6.4.1 Xi’An Efanggong Pharmaceutical Co.,Ltd. Corporation Information
6.4.2 Xi’An Efanggong Pharmaceutical Co.,Ltd. Description and Business Overview
6.4.3 Xi’An Efanggong Pharmaceutical Co.,Ltd. Niuhuangjiedu Pill Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Xi’An Efanggong Pharmaceutical Co.,Ltd. Niuhuangjiedu Pill Product Portfolio
6.4.5 Xi’An Efanggong Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.5 Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd.
6.5.1 Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd. Corporation Information
6.5.2 Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd. Niuhuangjiedu Pill Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd. Niuhuangjiedu Pill Product Portfolio
6.5.5 Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.6 CR Sanjiu
6.6.1 CR Sanjiu Corporation Information
6.6.2 CR Sanjiu Description and Business Overview
6.6.3 CR Sanjiu Niuhuangjiedu Pill Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CR Sanjiu Niuhuangjiedu Pill Product Portfolio
6.6.5 CR Sanjiu Recent Developments/Updates
6.7 Hubei Renyue Pharmaceutical Co., Ltd.
6.6.1 Hubei Renyue Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Hubei Renyue Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Hubei Renyue Pharmaceutical Co., Ltd. Niuhuangjiedu Pill Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hubei Renyue Pharmaceutical Co., Ltd. Niuhuangjiedu Pill Product Portfolio
6.7.5 Hubei Renyue Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Hubei NewLand Pharmaceutical Co., Ltd.
6.8.1 Hubei NewLand Pharmaceutical Co., Ltd. Corporation Information
6.8.2 Hubei NewLand Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Hubei NewLand Pharmaceutical Co., Ltd. Niuhuangjiedu Pill Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hubei NewLand Pharmaceutical Co., Ltd. Niuhuangjiedu Pill Product Portfolio
6.8.5 Hubei NewLand Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Li Shizhen Pharmaceutical Group Co., Ltd.
6.9.1 Li Shizhen Pharmaceutical Group Co., Ltd. Corporation Information
6.9.2 Li Shizhen Pharmaceutical Group Co., Ltd. Description and Business Overview
6.9.3 Li Shizhen Pharmaceutical Group Co., Ltd. Niuhuangjiedu Pill Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Li Shizhen Pharmaceutical Group Co., Ltd. Niuhuangjiedu Pill Product Portfolio
6.9.5 Li Shizhen Pharmaceutical Group Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Niuhuangjiedu Pill Industry Chain Analysis
7.2 Niuhuangjiedu Pill Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Niuhuangjiedu Pill Production Mode & Process
7.4 Niuhuangjiedu Pill Sales and Marketing
7.4.1 Niuhuangjiedu Pill Sales Channels
7.4.2 Niuhuangjiedu Pill Distributors
7.5 Niuhuangjiedu Pill Customers
8 Niuhuangjiedu Pill Market Dynamics
8.1 Niuhuangjiedu Pill Industry Trends
8.2 Niuhuangjiedu Pill Market Drivers
8.3 Niuhuangjiedu Pill Market Challenges
8.4 Niuhuangjiedu Pill Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer